Trials / Conditions / Peritoneal Mesothelioma

Peritoneal Mesothelioma

16 registered clinical trials studyying Peritoneal Mesothelioma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413	IDEAYA Biosciences	Phase 1
Recruiting	PTC-Guided Therapy for Peritoneal Mesothelioma NCT07330271	Beijing Tsinghua Chang Gung Hospital	N/A
Recruiting	IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Asse NCT06790706	Hospices Civils de Lyon	Phase 2
Recruiting	A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935	Memorial Sloan Kettering Cancer Center	Phase 2
Suspended	A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers NCT05337735	M.D. Anderson Cancer Center	Phase 2
Completed	A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothel NCT05041062	University of Chicago	Phase 2
Recruiting	Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosi NCT04847063	National Cancer Institute (NCI)	Phase 1
Suspended	Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) NCT03875144	Institut du Cancer de Montpellier - Val d'Aurelle	Phase 2
Completed	Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma NCT03867578	University of Chicago	N/A
Terminated	Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mes NCT03608618	MaxCyte, Inc.	Phase 1
Unknown	A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1 NCT02588131	Italian Network for Tumor Biotherapy Foundation	Phase 2
Completed	Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays NCT02834234	Hospices Civils de Lyon	—
Recruiting	Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed NCT01617382	Universitaire Ziekenhuizen KU Leuven	—
Completed	HIPEC for Peritoneal Carcinomatosis NCT02040142	Albert Einstein College of Medicine	Phase 2
Unknown	French National Registry of Rare Peritoneal Surface Malignancies NCT02834169	Hospices Civils de Lyon	—
Completed	Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy NCT01160458	National Cancer Institute (NCI)	Phase 2